Skip to content

Infectiology: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Infectiology

BE 0793.688.939
NACE 86.220, Specialist medical practice
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€29,050
2024 · €48,039-€18,989
Equity
€24,473
2024 · €122,776-€98,303
Cash
€26,597
2024 · €99,060-€72,462
Balance sheet total
€87,957
2024 · €155,547-€67,590

Largest movements

2024 to 2025
Assets
  • Cash -€72,462

    down €72,462 (-73.2%), from €99,060 to €26,597

    mainly Contributions, distributions and other (-€127,353) and Receivables within one year (-€17,838)

  • Receivables within one year +€17,838

    up €17,838 (+89.3%), from €19,966 to €37,804

    of which Trade receivables: +€17,838

  • Tangible fixed assets -€11,262

    down €11,262 (-33.2%), from €33,943 to €22,681

  • Deferred charges and accrued income -€1,703

    down €1,703 (-66.1%), from €2,579 to €875

Equity and liabilities
  • Profit (loss) carried forward -€98,303

    down €98,303 (-82.1%), from €119,776 to €21,473

  • Other debts +€41,452

    up €41,452 (+1,158%), from €3,578 to €45,031

  • Tax, wage and social debts -€9,069

    down €9,069 (-41.1%), from €22,059 to €12,990

    of which Taxes: -€10,829

  • Trade debts -€1,670

    down €1,670 (-23.4%), from €7,134 to €5,464

Income statement
  • Gross operating margin -€13,241

    down €13,241 (-19.7%), from €67,094 to €53,853

  • Depreciation +€10,158

    up €10,158 (+353%), from €2,876 to €13,034

  • Taxes -€3,737

    down €3,737 (-25.9%), from €14,411 to €10,675

  • Other operating charges -€1,068

    down €1,068 (-58.9%), from €1,813 to €745

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €48,039
Gross operating margin -€13,241
Depreciation -€10,158
Other operating charges +€1,068
Financial income -€30
Financial charges -€364
Taxes +€3,737
Result 2025 €29,050
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€56,662
Investment -€1,772
Financing -€127,353
Cash 2024 €99,060
Net result for the year +€29,050
Depreciation +€13,034
Receivables within one year -€17,838
Deferred charges and accrued income +€1,703
Trade debts -€1,670
Tax, wage and social debts -€9,069
Other debts +€41,452
Investment in fixed assets (net) -€1,772
Contributions, distributions and other -€127,353
Cash 2025 €26,597
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €155,547 €87,957 -€67,590 -43.5%
Fixed assets 21/28 €33,943 €22,681 -€11,262 -33.2%
Tangible fixed assets 22/27 €33,943 €22,681 -€11,262 -33.2%
Furniture and vehicles 24 €33,943 €22,681 -€11,262 -33.2%
Current assets 29/58 €121,604 €65,276 -€56,328 -46.3%
Amounts receivable within one year 40/41 €19,966 €37,804 +€17,838 +89.3%
Trade receivables 40 €19,966 €37,804 +€17,838 +89.3%
Other amounts receivable 41 - €0 =
Cash at bank and in hand 54/58 €99,060 €26,597 -€72,462 -73.2%
Deferred charges and accrued income 490/1 €2,579 €875 -€1,703 -66.1%
Total equity and liabilities 10/49 €155,547 €87,957 -€67,590 -43.5%
Equity 10/15 €122,776 €24,473 -€98,303 -80.1%
Contributions 10/11 €3,000 €3,000 = 0.0%
Profit (loss) carried forward 14 €119,776 €21,473 -€98,303 -82.1%
Amounts payable 17/49 €32,771 €63,485 +€30,713 +93.7%
Amounts payable within one year 42/48 €32,771 €63,485 +€30,713 +93.7%
Trade debts 44 €7,134 €5,464 -€1,670 -23.4%
Suppliers 440/4 €7,134 €5,464 -€1,670 -23.4%
Taxes, remuneration and social security 45 €22,059 €12,990 -€9,069 -41.1%
Taxes 450/3 €22,059 €11,230 -€10,829 -49.1%
Remuneration and social security 454/9 - €1,760 +€1,760
Other amounts payable 47/48 €3,578 €45,031 +€41,452 +1,158%
Non-recurring operating income 76A €1,072 - -€1,072
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,876 €13,034 +€10,158 +353%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €0 - =
Other operating charges 640/8 €1,813 €745 -€1,068 -58.9%
Gross operating margin 9900 €67,094 €53,853 -€13,241 -19.7%
Operating profit (loss) 9901 €62,405 €40,074 -€22,331 -35.8%
Financial income 75/76B €169 €139 -€30 -17.9%
Recurring financial income 75 €169 €139 -€30 -17.9%
Financial charges 65/66B €124 €488 +€364 +294%
Recurring financial charges 65 €124 €488 +€364 +294%
Profit (loss) for the period before taxes 9903 €62,450 €39,725 -€22,725 -36.4%
Income taxes 67/77 €14,411 €10,675 -€3,737 -25.9%
Profit (loss) for the period 9904 €48,039 €29,050 -€18,989 -39.5%
Profit (loss) for the period to be appropriated 9905 €48,039 €29,050 -€18,989 -39.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.